We propose to establish an NIH-supported research training program in Immunohematology and Transfusion Medicine designed to take MDs and MD/PhDs, who have fully completed their clinical training in these disciplines, and provide them with the tools to become productive physician-scientists with an abiding interest in basic science and translational research in these relatively underrepresented investigative areas. We believe that these biomedical scientists should be trained in an environment that emphasizes basic biological processes and which simultaneously provides continuous didactic exposure to those state-of-the-art investigative issues which are relatively unique to immunohernatology and transfusion medicine, e.g., transfusion-induced immunomodulation, cellular alteration and apoptosis during ex vivo storage, cell engineering pretransfusion, and allo- and auto- immunity to circulating cells and plasma proteins. Our interdisciplinary and multi-departmental faculty include 21 investigators (19 senior and 2 junior, including MDs, MD/PhDs and PhDs) who have a long history of collaborative publications, trainees and grants and whose laboratories are very experienced in the simultaneous training of post-doctoral PhDs, post doctoral MDs and pre-doctoral PhD candidates. We have the educational philosophy that trainees in this program must have their core experience at the bench, that they require carefully crafted training and career guidance by an individualized trainee committee somewhat analogous to a pre-doctoral thesis committee, and that we must provide ongoing venues for them to interact on a one-to-one basis with additional internationally recognized investigator's in immunohematology and transfusion who are from other institutions. In the 1st year of the grant we are requesting support for one post-doctoral position and thereafter for support of 2 post-doctoral positions each year. We expect that MD trainees will require 2-3 years of training at this level before moving to a K-award equivalent and MD/PhDs 1-2 years with one new trainee added to the program each year. We have had past successful experience training exactly the same type of individuals we propose for this T32 but using mechanisms of support other than a T32 (individual NRSAs, research fellowships from foundations and the like). Those individuals have all gone on to successful academic careers. We believe strongly that an institutional T32 would provide a markedly enhanced, coordinated and formalized training experience for this type of clinician-scientist and provide a smoother pathway for these individuals to move to the next level of independence and eventually comprise the next generation of clinician-scientists who can bridge the gap between fundamental research and clinical need in immunohematology and transfusion.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007974-04
Application #
6790694
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F1))
Program Officer
Mondoro, Traci
Project Start
2001-08-01
Project End
2006-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
4
Fiscal Year
2004
Total Cost
$103,983
Indirect Cost
Name
Yale University
Department
Pathology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Hauser, Ronald George; Quine, Douglas B; Ryder, Alex (2018) LabRS: A Rosetta stone for retrospective standardization of clinical laboratory test results. J Am Med Inform Assoc 25:121-126
Zhang, Feng; Zarkada, Georgia; Han, Jinah et al. (2018) Lacteal junction zippering protects against diet-induced obesity. Science 361:599-603
Hauser, Ronald G; Quine, Douglas B; Ryder, Alex et al. (2018) Unit conversions between LOINC codes. J Am Med Inform Assoc 25:192-196
Juchem, Kathryn W; Sacirbegovic, Faruk; Zhang, Cuiling et al. (2018) PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease. J Immunol 200:834-846
Gibb, David R; Liu, Jingchun; Natarajan, Prabitha et al. (2017) Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice. J Immunol 199:1041-1050
Natarajan, Prabitha; Liu, Jingchun; Santhanakrishnan, Manjula et al. (2017) Bortezomib decreases the magnitude of a primary humoral immune response to transfused red blood cells in a murine model. Transfusion 57:82-92
Sweet, Rebecca A; Nickerson, Kevin M; Cullen, Jaime L et al. (2017) B Cell-Extrinsic Myd88 and Fcer1g Negatively Regulate Autoreactive and Normal B Cell Immune Responses. J Immunol 199:885-893
Iwasaki, Akiko; Foxman, Ellen F; Molony, Ryan D (2017) Early local immune defences in the respiratory tract. Nat Rev Immunol 17:7-20
Uraki, Ryuta; Jurado, Kellie Ann; Hwang, Jesse et al. (2017) Fetal Growth Restriction Caused by Sexual Transmission of Zika Virus in Mice. J Infect Dis 215:1720-1724
Gettinger, Scott; Choi, Jungmin; Hastings, Katherine et al. (2017) Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer. Cancer Discov 7:1420-1435

Showing the most recent 10 out of 134 publications